IS4868A - Treatment of dementia-associated infections of the benign amide virus (HIV-1) with benzamide - Google Patents

Treatment of dementia-associated infections of the benign amide virus (HIV-1) with benzamide

Info

Publication number
IS4868A
IS4868A IS4868A IS4868A IS4868A IS 4868 A IS4868 A IS 4868A IS 4868 A IS4868 A IS 4868A IS 4868 A IS4868 A IS 4868A IS 4868 A IS4868 A IS 4868A
Authority
IS
Iceland
Prior art keywords
benzamide
dementia
benign
hiv
virus
Prior art date
Application number
IS4868A
Other languages
Icelandic (is)
Inventor
Garland William
Original Assignee
Centaur Pharmaceuticals, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Centaur Pharmaceuticals, Inc. filed Critical Centaur Pharmaceuticals, Inc.
Publication of IS4868A publication Critical patent/IS4868A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/166—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the carbon of a carboxamide group directly attached to the aromatic ring, e.g. procainamide, procarbazine, metoclopramide, labetalol

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
IS4868A 1996-04-17 1998-10-16 Treatment of dementia-associated infections of the benign amide virus (HIV-1) with benzamide IS4868A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US1571096P 1996-04-17 1996-04-17
PCT/US1997/006351 WO1997038684A1 (en) 1996-04-17 1997-04-17 Benzamide treatment of dementia associated with aids virus (hiv-1) infection

Publications (1)

Publication Number Publication Date
IS4868A true IS4868A (en) 1998-10-16

Family

ID=21773101

Family Applications (1)

Application Number Title Priority Date Filing Date
IS4868A IS4868A (en) 1996-04-17 1998-10-16 Treatment of dementia-associated infections of the benign amide virus (HIV-1) with benzamide

Country Status (11)

Country Link
EP (1) EP0912171A1 (en)
CN (1) CN1218399A (en)
AP (1) AP898A (en)
AU (1) AU720578B2 (en)
BR (1) BR9708720A (en)
CA (1) CA2252403A1 (en)
IS (1) IS4868A (en)
NZ (1) NZ332438A (en)
OA (1) OA10901A (en)
TW (1) TW412421B (en)
WO (1) WO1997038684A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ534884A (en) 2002-02-13 2007-05-31 Creagri Inc Method and composition for treatment of inflammation and AIDS-associated neurological disorders
JP6750177B2 (en) * 2015-12-11 2020-09-02 ロート製薬株式会社 Anthranilamide derivative and therapeutic agent for diseases involving TLR3 containing the same

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5472983A (en) * 1994-04-14 1995-12-05 Centaur Pharmaceuticals, Inc. Benzamide-containing pharmaceutical compositions
IL117629A (en) * 1995-04-03 2000-08-13 Centaur Pharmaceuticals Inc Pharmaceutical compositions containing a benzamide derivative and methods for the preparation thereof

Also Published As

Publication number Publication date
WO1997038684A1 (en) 1997-10-23
TW412421B (en) 2000-11-21
BR9708720A (en) 2000-01-04
CN1218399A (en) 1999-06-02
AP898A (en) 2000-11-17
AU720578B2 (en) 2000-06-08
CA2252403A1 (en) 1997-10-23
OA10901A (en) 2002-02-14
EP0912171A1 (en) 1999-05-06
AP9801368A0 (en) 1998-12-31
AU2732297A (en) 1997-11-07
NZ332438A (en) 2001-02-23

Similar Documents

Publication Publication Date Title
ID27457A (en) COMPOSITION FOR HIV TREATMENT AND OTHER VIRUS INFECTIONS
DK0914103T3 (en) Treatment of hemoglobinopathy
NO991700D0 (en) Benzimidazole-2-carbamates for the treatment of viral infections and cancer
IS2567B (en) Combinations against viruses
AR027938A1 (en) URACILO COMPOUNDS AND USE OF THE SAME
DK1147083T3 (en) Arylpiperazinyl-cyclohexylindole derivatives for the treatment of depression
DK1017408T3 (en) Use of tetrahydrolipstatin in the treatment of type II diabetes
DK1073416T3 (en) Use of NO as an anti-inflammatory agent
TR199801513A3 (en) N- (4-Trifluoromethylphenyl) - 5- methyl-isoxazole-4-carboxamide crystal form.
IS7343A (en) N- (3-butyn-1-yl) N-hydroxy urea
DE60021065D1 (en) VIRUS TREATMENT
ID23780A (en) NITRIC OXIDER INHIBITING PHINOVIRUS INFECTION
DE69913556D1 (en) MANUFACTURE OF AMINES
NO940810D0 (en) Treatment of viral infections
PT1220858E (en) OXAZINOQUINOLONES UTEIS FOR THE TREATMENT OF VIRAL INFECTIONS
BR9507537A (en) Heterocyclyl benzonitriles
ID16394A (en) ONLY USE OF THE VARIOUS TYPES OF PANTS
FI956015A7 (en) Use of 5-acyl-1,4-dihydropyridines
DK0941081T3 (en) New use of creatine
EA200000875A1 (en) PROTEINS INTERACTING WITH CASPASE-8
FI19992661A7 (en) Use of applications in the telecommunications system
DK1607090T3 (en) Azimadoline for the treatment of Irritable Bowel Syndrome
DK0689577T3 (en) Use of ferronene
ATE267598T1 (en) VIRUS TREATMENT
DK0820284T3 (en) Biologically active ureido derivatives useful in the treatment of multiple sclerosis